Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Tensi+ for Treating Overactive Bladder

The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.

Participants needed: 60
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Stimuli TechnologyUpdated: Apr 28, 2026Locations: 3
Eligibility criteria

Adult subjects aged 22 years or older and, [+6]

Patients with pacemakers or implanted defibrillators or any other implanted elec... [+16]

Status: Recruiting

Tensi+ European Registry

Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) management. Preliminary studies have shown a favorable safety and efficacy profile. The goal of the present registry is to collect data among an important number of patients to assess the efficacy, safety and potential predictive factors of success in a current clinical setting over a total period of 1 year.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Stimuli TechnologyUpdated: Oct 3, 2025Locations: 17Duration: 1 Year
Eligibility criteria

Age ≥ 18 years [+1]

Patients with pacemaker, defibrillator, or any other electronic implant; [+6]